Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-30
DOI
10.1007/s10637-018-0686-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells
- (2018) Nazlıhan Aztopal et al. CHEMICO-BIOLOGICAL INTERACTIONS
- PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo
- (2017) Hiromasa Kuroda et al. Immunotherapy
- Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells
- (2017) Kai Liu et al. MOLECULAR CELL
- Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
- (2017) Lihui Wang et al. Cell Death & Disease
- Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
- (2017) Lucia Martinez-Cruzado et al. NEOPLASIA
- Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
- (2016) Ryoko Takahashi et al. PLoS One
- Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation
- (2015) Chiharu Miyajima et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
- (2015) Bo Wook Kim et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cervical cancer stem cells: opportunities and challenges
- (2015) Ravindresh Chhabra JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Novel Histone Deacetylase Inhibitors Induce Growth Arrest, Apoptosis, and Differentiation in Sarcoma Cancer Stem Cells
- (2015) Gemma Di Pompo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer
- (2015) Shuyan Liu et al. Oncotarget
- First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors
- (2014) M. E. Elez et al. CLINICAL CANCER RESEARCH
- Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells
- (2014) Shoko Kumazawa et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer
- (2014) Donatella Del Bufalo et al. Molecular Cancer
- Enrichment and characterization of cancer stem-like cells from a cervical cancer cell line
- (2014) LI WANG et al. Molecular Medicine Reports
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck
- (2013) Kazuaki Chikamatsu et al. CANCER SCIENCE
- The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
- (2013) M. A. Salvador et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
- (2013) Aidan G. Major et al. Stem Cells International
- Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance
- (2012) Jacqueline López et al. BMC CANCER
- Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer
- (2012) A. Vidal et al. CLINICAL CANCER RESEARCH
- Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials
- (2012) Charles A. Leath et al. GYNECOLOGIC ONCOLOGY
- Prediction of Progression-Free Survival and Response to Paclitaxel Plus Carboplatin in Patients With Recurrent or Advanced Cervical Cancer
- (2012) Takeshi Hisamatsu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells
- (2012) Mangmang Li et al. MOLECULAR CELL
- PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity
- (2010) JFM Leal et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study
- (2009) David H. Moore et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now